Supply Chain Map
ARDXCIK 1437402

ARDELYX, INC.

EDGAR filings
Customers
5
5 active
Suppliers
0
None disclosed
Largest customer
76.3%
BioRidge Pharma, LLC · 3M to 2026-06-30
Named-customer revenue
$162.6M
5 customers · 3M to 2026-06-30
Latest period
Jun 30, 2026
10-Q filed 2026-08-06
SuppliersCustomersNo supplier discloses itBioRidge Pharma, LLC65.9% · $268.4MBioRidge Pharma, LLC · 65.9% of ARDX revenue · $268.4M · FY to 2025-12-31 · 10-K filed 2026-02-19CAH21.4% · $87.2MCAH · 21.4% of ARDX revenue · $87.2M · FY to 2025-12-31 · 10-K filed 2026-02-19MCK17.9% · $72.9MMCK · 17.9% of ARDX revenue · $72.9M · FY to 2025-12-31 · 10-K filed 2026-02-19COR17.3% · $70.5MCOR · 17.3% of ARDX revenue · $70.5M · FY to 2025-12-31 · 10-K filed 2026-02-19CVS13.4% · $16.2MCVS · 13.4% of ARDX revenue · $16.2M · 3M to 2026-06-30 · 10-Q filed 2026-08-06ARDX
Band height is the estimated dollar value: the disclosed share × the discloser's revenue for that period (latest full year where available). Thin bands are named without a figure. Click a band to open its filing.

Customers 5

Companies ARDX discloses as major customers, as a share of ARDX revenue. 5 active, 0 lapsed.

Company% of ARDX revenueEst. revenuePeriodTrendStatusSource
BioRidge Pharma, LLC Non-SEC
BioRidge Pharma, LLC
 76.3%$92.2M 3M 2026-06-30
3M ending 2024-09-30: 78.1%3M ending 2025-03-31: 63.8%3M ending 2025-06-30: 61.1%3M ending 2025-09-30: 66.3%3M ending 2026-03-31: 85.5%3M ending 2026-06-30: 76.3%−9.2pp
Active 10-Q 2026-08-06
BioRidge Pharma, LLC 76.3 % 61.1 % 80.3 % 62.2 %
10-Q filed 2026-08-06 Period 3M 2026-04-01 to 2026-06-30 (76.3%), 3M 2025-04-01 to 2025-06-30 (61.1%)Accession 0001437402-26-000044
BioRidge Pharma, LLC 85.5 % 63.8 %
10-Q filed 2026-04-30 Period 3M 2026-01-01 to 2026-03-31 (85.5%), 3M 2025-01-01 to 2025-03-31 (63.8%)Accession 0001437402-26-000022
BioRidge Pharma, LLC 65.9 % 75.4 % 24.0 %
10-K filed 2026-02-19 Period FY 2025-01-01 to 2025-12-31 (65.9%), FY 2024-01-01 to 2024-12-31 (75.4%), FY 2023-01-01 to 2023-12-31 (24%)Accession 0001437402-26-000013
BioRidge Pharma, LLC 66.3 % 78.1 % 63.8 % 76.0 %
10-Q filed 2025-10-30 Period 3M 2025-07-01 to 2025-09-30 (66.3%), 3M 2024-07-01 to 2024-09-30 (78.1%)Accession 0001437402-25-000018
COR Distributor
Cencora, Inc.
 16%$19.3M 3M 2026-06-30
3M ending 2024-09-30: 13.8%3M ending 2025-03-31: 18.2%3M ending 2025-06-30: 20.5%3M ending 2025-09-30: 17.3%3M ending 2026-03-31: 17.2%3M ending 2026-06-30: 16%−1.2pp
Active 10-Q 2026-08-06
Cencora, Inc. 16.0 % 20.5 % 16.5 % 19.5 %
10-Q filed 2026-08-06 Period 3M 2026-04-01 to 2026-06-30 (16%), 3M 2025-04-01 to 2025-06-30 (20.5%)Accession 0001437402-26-000044
Cencora, Inc. 17.2 % 18.2 %
10-Q filed 2026-04-30 Period 3M 2026-01-01 to 2026-03-31 (17.2%), 3M 2025-01-01 to 2025-03-31 (18.2%)Accession 0001437402-26-000022
Cencora (formerly AmerisourceBergen Drug Corporation) 17.3 % 16.4 % 19.1 %
10-K filed 2026-02-19 Period FY 2025-01-01 to 2025-12-31 (17.3%), FY 2024-01-01 to 2024-12-31 (16.4%), FY 2023-01-01 to 2023-12-31 (19.1%)Accession 0001437402-26-000013
Cencora (formerly AmerisourceBergen Drug Corporation) 17.3 % 13.8 % 18.6 % 15.9 %
10-Q filed 2025-10-30 Period 3M 2025-07-01 to 2025-09-30 (17.3%), 3M 2024-07-01 to 2024-09-30 (13.8%)Accession 0001437402-25-000018
CAH Distributor
CARDINAL HEALTH INC
 14.4%$17.4M 3M 2026-06-30
3M ending 2024-09-30: 12.4%3M ending 2025-03-31: 22.2%3M ending 2025-06-30: 23.4%3M ending 2025-09-30: 25.5%3M ending 2026-03-31: 12.8%3M ending 2026-06-30: 14.4%+1.6pp
Active 10-Q 2026-08-06
Cardinal Health, Inc. 14.4 % 23.4 % 13.7 % 22.8 %
10-Q filed 2026-08-06 Period 3M 2026-04-01 to 2026-06-30 (14.4%), 3M 2025-04-01 to 2025-06-30 (23.4%)Accession 0001437402-26-000044
Cardinal Health, Inc. 12.8 % 22.2 %
10-Q filed 2026-04-30 Period 3M 2026-01-01 to 2026-03-31 (12.8%), 3M 2025-01-01 to 2025-03-31 (22.2%)Accession 0001437402-26-000022
Cardinal Health 21.4 % 14.5 % 19.8 %
10-K filed 2026-02-19 Period FY 2025-01-01 to 2025-12-31 (21.4%), FY 2024-01-01 to 2024-12-31 (14.5%), FY 2023-01-01 to 2023-12-31 (19.8%)Accession 0001437402-26-000013
Cardinal Health 25.5 % 12.4 % 23.9 % 14.6 %
10-Q filed 2025-10-30 Period 3M 2025-07-01 to 2025-09-30 (25.5%), 3M 2024-07-01 to 2024-09-30 (12.4%)Accession 0001437402-25-000018
MCK Distributor
MCKESSON CORP
 14.4%$17.4M 3M 2026-06-30
3M ending 2024-09-30: 13%3M ending 2025-03-31: 16.9%3M ending 2025-06-30: 20.7%3M ending 2025-09-30: 20.7%3M ending 2026-03-31: 15.7%3M ending 2026-06-30: 14.4%−1.3pp
Active 10-Q 2026-08-06
McKesson Corporation 14.4 % 20.7 % 15.0 % 19.1 %
10-Q filed 2026-08-06 Period 3M 2026-04-01 to 2026-06-30 (14.4%), 3M 2025-04-01 to 2025-06-30 (20.7%)Accession 0001437402-26-000044
McKesson Corporation 15.7 % 16.9 %
10-Q filed 2026-04-30 Period 3M 2026-01-01 to 2026-03-31 (15.7%), 3M 2025-01-01 to 2025-03-31 (16.9%)Accession 0001437402-26-000022
McKesson Corporation 17.9 % 14.1 % 15.7 %
10-K filed 2026-02-19 Period FY 2025-01-01 to 2025-12-31 (17.9%), FY 2024-01-01 to 2024-12-31 (14.1%), FY 2023-01-01 to 2023-12-31 (15.7%)Accession 0001437402-26-000013
McKesson Corporation 20.7 % 13.0 % 19.7 % 13.9 %
10-Q filed 2025-10-30 Period 3M 2025-07-01 to 2025-09-30 (20.7%), 3M 2024-07-01 to 2024-09-30 (13%)Accession 0001437402-25-000018
CVS
CVS HEALTH Corp
 13.4%$16.2M 3M 2026-06-30
3M ending 2026-03-31: 12.1%3M ending 2026-06-30: 13.4%+1.3pp
Active 10-Q 2026-08-06
Caremark, LLC 13.4 % — % 12.8 % — %
10-Q filed 2026-08-06 Period 3M 2026-04-01 to 2026-06-30 (13.4%)Accession 0001437402-26-000044
Caremark, LLC 12.1 % — %
10-Q filed 2026-04-30 Period 3M 2026-01-01 to 2026-03-31 (12.1%)Accession 0001437402-26-000022

Alerts are coming

Get an email when ARDX's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.

We store only your email, the page you signed up from and the time. Privacy